Orbifloxacin
From Wikipedia, the free encyclopedia
This article does not cite any references or sources. (May 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Orbifloxacin
|
|
Systematic (IUPAC) name | |
1-Cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C19H20F3N3O3 |
Mol. mass | 395.37 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
veterinary use only |
Routes | Oral |
Orbifloxacin (brand name Orbax) is a is a fluoroquinolone antibiotic which is approved for use in dogs, marketed by Schering-Plough Animal Health.
|